Effects of Body Weight Reduction on Serum Irisin and Metabolic Parameters in Obese Subjects.
10.4093/dmj.2016.40.5.386
- Author:
Yaeko FUKUSHIMA
1
;
Satoshi KUROSE
;
Hiromi SHINNO
;
Ha Cao THI THU
;
Nana TAKAO
;
Hiromi TSUTSUMI
;
Takaaki HASEGAWA
;
Toshiaki NAKAJIMA
;
Yutaka KIMURA
Author Information
1. Department of Health Science, Kansai Medical University Graduate School of Medicine, Hirakata, Japan. bsk-80@outlook.com
- Publication Type:Original Article
- Keywords:
Body composition;
Insulin resistance;
Irisin;
Lean muscle mass;
Obesity
- MeSH:
Adipose Tissue;
Asian Continental Ancestry Group;
Body Composition;
Body Mass Index;
Body Weight*;
Cognitive Therapy;
Diet;
Exercise Therapy;
Exercise Tolerance;
Fasting;
Glucose;
Homeostasis;
Humans;
Insulin;
Insulin Resistance;
Kinetics;
Metabolism;
Obesity;
Subcutaneous Fat;
Triglycerides
- From:Diabetes & Metabolism Journal
2016;40(5):386-395
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Irisin is a myokine implicated in lipid and glucose metabolism. The objective of this study is to examine the effect of a body weight reduction on the serum irisin level and physical indicators in obese Japanese patients without diabetes. METHODS: The subjects were 22 patients (male/female, 5/17; age, 46.1±16.0 years; body mass index [BMI], 36.9±5.0 kg/m²) who completed a 6-month body weight reduction program at our clinic. The program included diet, exercise therapy and cognitive behavioral therapy. Blood parameters, body composition, exercise tolerance, homeostasis model assessment of insulin resistance (HOMA-IR), and serum irisin were determined before and after intervention, and relationships among changes in these data were examined. RESULTS: There were significant decreases in body weight and BMI after the intervention. Irisin before the intervention was significantly positively correlated with HOMA-IR (r=0.434, P<0.05). The mean irisin level showed no significant change after the intervention in all participants. However, improvements in % body fat, subcutaneous fat area, triglycerides, and fasting glucose were significantly greater in patients with an increase in irisin compared to those with a decrease in irisin after the intervention. Patients with an increase in irisin also had significantly lower fasting insulin (9.7±4.8 vs. 16.4±8.2, P<0.05) and HOMA-IR (2.2±1.1 vs. 3.7±1.6, P<0.05) after the intervention, compared to patients with a decrease in irisin. CONCLUSION: Body weight reduction did not alter irisin levels. However, irisin may play important roles in fat and glucose metabolism and insulin resistance, and the effects of body weight reduction on irisin kinetics may be a key for obesity treatment.
